The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




Summit Therapeutics plc - SUMM Summit Highlights Microbiome Preservation During Ridinilazole Treatment at ID Week 2017
12:00 09-Oct-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : Exercise of Options
16:25 05-Oct-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Highlights DMD Biomarker Validation Data at 22nd WMS Congress
12:00 04-Oct-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : Exercise of Options
11:15 03-Oct-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics to Host R&D Day 11 October 2017
12:00 02-Oct-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : Exercise of Share Options
18:20 29-Sep-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : Exercise of Share Options
17:15 28-Sep-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Joins cTAP in Effort to Enhance Development of Utrophin Modulators and Other Treatments for DMD
12:00 25-Sep-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics Announces Closing of its ADS Public Offering Raising USD20.1M Before Expenses
18:00 18-Sep-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics Announces Exercise of Underwriters' Over-Allotment Option
18:29 15-Sep-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Announces Underwritten Public Offering of 1,459,000 ADSs to Raise USD17.5 Million Before Expenses
07:00 14-Sep-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics Awarded BARDA Contract Worth Up To $62M To Support Development of Ridinilazole for CDI
12:00 11-Sep-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : Positive Top-line Phase 2 Results
12:00 05-Sep-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics plc : Half-yearly report
12:00 31-Aug-2017  ONE  0.00% View chart
Summit Therapeutics plc - SUMM Summit Therapeutics to Present at the Canaccord Genuity Growth Conference
12:00 03-Aug-2017  ONE  0.00% View chart


RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


about rns

 

News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds